Hi-tech bone marrow transplant centre inaugurated in city

It offers healthcare for cancerous and non-cancerous conditions

May 17, 2019 12:41 am | Updated 07:32 am IST - VISAKHAPATNAM

MGCHRI Managing Director V. Murali Krishna explaining about the equipment installed at the bone marrow transplant unit in Visakhapatnam on Thursday.

MGCHRI Managing Director V. Murali Krishna explaining about the equipment installed at the bone marrow transplant unit in Visakhapatnam on Thursday.

A ‘Centre for Advanced Haematology and Haemato-Oncology’ (bone marrow transplant unit) of the Mahatma Gandhi Cancer Hospital and Research Institute (MGCHRI) was inaugurated at Unique Hospital premises in Health City, Arilova, on Thursday. This is said to be the first such facility of its kind in Andhra Pradesh.

Facilities galore

Equipped with four transplant suites and well trained experts in haematology and haemato-oncology, the unit can offers both autologous and allonogeneic stem cell transplantation facilities.

BMT procedures can treat cancerous conditions such as leukaemia, myeloma, lymphoma and non-cancerous conditions such as aplastic anaemia, sickle cell anaemia, thalassaemia and immuno-deficiency disorders, MGCHRI Managing Director Dr. Voona Murali Krishna told the media here.

The unit has a core team of professionals – Dr. B. Rakesh Reddy, senior medical oncologist, Dr. Chandrasekhar, consultant haematologist, Dr. Praveena Voona, consultant medical oncologist and Dr. G. Veniprasanna, pathologist.

Robotic surgery

“The MGCHRI which has completed 13 years of services in cancer care has also achieved another milestone of completing 100 robotic surgeries,” Dr. Murali Krishna said.

Dr. K. Radha Krishna, senior paediatrician and neo-natologist Dr. K. Vishnu Prasad, senior neuro-surgeon and former DME, Dr. R. Madan Mohan, senior haematologist and haemato-oncologist were present on the occasion.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.